Background Conventional surgical risk scores lack accuracy in risk stratification of patients
undergoing transcatheter aortic valve replacement (TAVR). Elevated levels of midregional …

Background: This study aimed to assess the association of mid-regional (MR) pro-
adrenomedullin (MR-proADM) and MR-pro-A-type natriuretic peptide (MR-proANP) in …

Objective We investigated the prognostic significance of selected known and novel
circulating biomarkers in aortic stenosis (AS). Methods N-terminal pro-BNP (NT-proBNP) …

High levels of the plasma peptides mid-regional pro-adrenomedullin (MR-proADM) and mid-
regional pro-atrial natriuretic peptide (MR-proANP) are associated with clinical outcomes in …

Aims The aim of this study was to evaluate the long‐term prognostic utility of mid‐region
prohormone adrenomedullin (MR‐proADM) in stable outpatients with heart failure (HF) …

Background and Objectives: The aim of this paper is to evaluate the impact of humoral
substance mid-regional pro-adrenomedullin (MR-proADM) on the two-year survival of …

Objective Experimental studies have shown that adrenomedullin (ADM) has an important
role in circulatory homeostasis. Mid-regional pro-ADM (MR-proADM) is a stable form of …

Background Diabetes mellitus (DM) is associated with an adverse outcome in heart failure
(HF). Increased concentrations of midregional proadrenomedullin (MR-proADM) have been …

Objective To assess the cardiovascular prognostic value of mid-regional pro-
adrenomedullin (MR-proADM) and compare this with B-type natriuretic peptide (BNP) and N …

Aims Whereas guidelines recommend the routine use of natriuretic peptides (NPs) in heart
failure (HF) care, the clinical relevance and prognostic potential of midregional pro …